6-36371389-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_016135.4(ETV7):āc.605C>Gā(p.Thr202Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,602,410 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_016135.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ETV7 | NM_016135.4 | c.605C>G | p.Thr202Ser | missense_variant | 5/8 | ENST00000340181.9 | NP_057219.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ETV7 | ENST00000340181.9 | c.605C>G | p.Thr202Ser | missense_variant | 5/8 | 1 | NM_016135.4 | ENSP00000341843 | P2 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151872Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000131 AC: 3AN: 229242Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 123972
GnomAD4 exome AF: 0.0000110 AC: 16AN: 1450538Hom.: 0 Cov.: 32 AF XY: 0.00000972 AC XY: 7AN XY: 720470
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151872Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74186
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 12, 2021 | The c.605C>G (p.T202S) alteration is located in exon 5 (coding exon 5) of the ETV7 gene. This alteration results from a C to G substitution at nucleotide position 605, causing the threonine (T) at amino acid position 202 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at